BIOND health

BIOND the booth 2: the unseen majority

Designing congress impact beyond the booth, beyond the venue and beyond the attendees.

In partnership withSpace & Time

← All events

Invite-only working sessionNo.4 Hamilton Place, Mayfair, London

Chapter 1 showed that the booth of one European dermatology congress met 1.3% of Europe's dermatologists. Chapter 2 set out to design for the other 98.7%: the HCPs who never came, came but never visited the booth, or stayed in clinic with their patients.

Not a panel but a working morning. Two teams of pharma leaders took on three challenges: a myth clinic with Dr Dev to kill the assumptions first, a congress shop to spend a fixed budget on pre and peri congress, and a media engine to make the science travel for six weeks afterwards.

What the room took away

  • Kill the myths first: what pharma assumes HCPs want rarely matches why they come
  • Ask how to make the congress science travel, not how to drive more booth traffic
  • What you buy before the congress is what you will have to amplify after it

A sample of the pharma companies around the table

  • Gilead
  • Novo Nordisk
  • Sandoz
  • CSL Vifor

Want to bring this conversation to your team?

Book a black belt session
45 minutes with Yacin M. Free. On video.Or write to yacin.m@biond.health

Or send a message